You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 28, 2025

Drug Price Trends for NDC 16714-0121


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 16714-0121

Drug NameNDCPrice/Unit ($)UnitDate
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.35037 EACH 2025-04-23
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.35110 EACH 2025-03-19
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.31457 EACH 2025-02-19
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.26994 EACH 2025-01-22
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.26834 EACH 2024-12-18
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.19978 EACH 2024-11-20
PILOCARPINE HCL 5 MG TABLET 16714-0121-01 0.33687 EACH 2024-10-23
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 7 of 7 entries

Best Wholesale Price for NDC 16714-0121

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 16714-0121

Understanding the NDC Code

The National Drug Code (NDC) is a unique identifier assigned to each drug product, facilitating tracking and analysis of market trends. The NDC 16714-0121 corresponds to a specific formulation of a drug, in this case, a combination product containing dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate[1].

Drug Profile

The drug identified by NDC 16714-0121 is a single-entity amphetamine product, combining the neutral sulfate salts of dextroamphetamine and amphetamine, along with the dextro isomer of amphetamine saccharate. This medication is classified as a Schedule CII controlled substance, indicating its potential for abuse and dependence[1].

Current Pricing

To analyze the current pricing of the drug with NDC 16714-0121, one must refer to the latest data from sources such as the FDA's National Drug Code Directory or market analytics databases. As of the latest updates, specific pricing details for this NDC are not provided in the public domain, but prices can be obtained from pharmacy benefit managers, insurance companies, or directly from the manufacturer or packager, NorthStar RxLLC[1][5].

Historical Price Changes

Historical price changes for this drug can offer insights into pricing patterns. Drugs in the pharmaceutical market, especially those with limited competition, often experience price increases, particularly in January and July. These increases can be significant, with an average rise of around $150 per drug, although this can vary based on market conditions and regulatory changes[4].

Market Demand and Competition

The market demand for this drug is influenced by its therapeutic use and the availability of alternative treatments. As a medication for conditions such as ADHD and narcolepsy, it has a dedicated market. However, the presence of generic alternatives and other branded products can impact its pricing strategy. If the drug has limited competitors, it may have more room for price increases[4].

Regulatory Environment

Regulatory changes can significantly affect drug pricing. For instance, policies aimed at controlling price increases or promoting generic alternatives can impact the pricing strategy for this drug. The pharmaceutical industry is also subject to broader regulatory trends, such as those related to patient-centered care, precision medicine, and the use of AI/ML technologies, which can influence pricing and market dynamics[3][4].

Price Projections

Short-Term Projections

Given historical trends, it is likely that the drug with NDC 16714-0121 could experience price increases in January and July. These increases are often aligned with industry-wide practices and can be influenced by factors such as production costs, market demand, and regulatory changes. The average increase could be around $150 per drug, although this can vary based on specific market conditions[4].

Long-Term Projections

Long-term price projections need to consider broader market trends, including the growth of the biopharma and biotech industries, international price comparisons, and regulatory changes. If this drug is part of a segment seeing significant innovation and demand, such as treatments for ADHD or narcolepsy, it may continue to see price increases above the general inflation rate.

Industry Trends

The pharmaceutical industry is undergoing significant transformations, with a focus on prevention, personalization, prediction, and point of care. These trends are expected to shape the future of pharma, including how drugs are priced and delivered. The use of data-driven, customized treatments and early intervention strategies could impact the demand and pricing of drugs like those identified by NDC 16714-0121[3].

International Comparisons

U.S. drug prices are often significantly higher than in other countries. This disparity can influence pricing strategies, especially if there are regulatory or policy changes aimed at aligning U.S. prices with international standards. However, the unique regulatory and market environment in the U.S. often results in higher prices compared to other regions[4].

Key Takeaways

  • NDC Understanding: The NDC is crucial for tracking and analyzing market trends for specific drug products.
  • Historical Price Changes: Significant price increases often occur in January and July.
  • Market Demand and Competition: The presence of competitors and the therapeutic use of the drug influence its pricing.
  • Regulatory Impact: Changes in regulations can significantly affect drug pricing strategies.
  • Industry Trends: The biopharma and biotech industries are rapidly evolving, impacting drug pricing and availability.

FAQs

Q: What is the NDC code, and why is it important? A: The National Drug Code (NDC) is a unique identifier for each drug product, facilitating tracking and analysis of market trends. It is crucial for ensuring the correct drug is prescribed and dispensed.

Q: How often do price increases occur for drugs like NDC 16714-0121? A: Price increases for drugs often occur in January and July, with an average increase of around $150 per drug, although this can vary based on market conditions.

Q: What factors influence the pricing of drugs in the pharmaceutical market? A: Pricing is influenced by factors such as market demand, competition, regulatory changes, and broader industry trends like the focus on prevention, personalization, and precision medicine.

Q: How do regulatory changes impact drug pricing? A: Regulatory changes, such as policies aimed at controlling price increases or promoting generic alternatives, can significantly affect the pricing strategy for drugs.

Q: What are the broader industry trends that could impact the pricing of NDC 16714-0121? A: Trends such as the focus on prevention, personalization, prediction, and point of care, along with the use of AI/ML technologies and shifts in regulatory frameworks, can influence the pricing and availability of drugs.

Sources

  1. DailyMed: DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE AND AMPHETAMINE SULFATE tablet.
  2. Missouri Specialty MAC: MISSOURI SPECIALTY MAC NAME OF DRUG Strength NDC Price Effective January 1, 2023.
  3. PwC: Pharma industry trends: PwC.
  4. DrugPatentWatch: Latest drug prices and trends for NDC 67457-0212.
  5. FDA: National Drug Code Directory - FDA.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.